AptarGroup, Inc.

aptar.com

What Do They Do?

Makes drug-delivery systems and injectable-drug packaging for pharmaceutical and health-care customers, alongside dispensing and sealing products for consumer brands.

How Do They Make Money?

Most revenue comes from product, tooling and service sales. Product customers are invoiced at shipment and typically pay shortly after; tooling payments come during the mold build or shortly after completion, while services are tied to milestone deliverables and upfront payments.

revenue

Segment	Share	How money arrives
Pharma Sold outright	46%	Sold outright
Beauty Sold outright	35%	Sold outright
Closures Sold outright	19%	Sold outright

Who Are Their Customers?

Aptar sells to pharmaceutical and health-care companies, beauty and personal-care brands, and food and beverage marketers.

Do Revenues Turn Into Profits?

Yes. It kept 10 cents of every revenue dollar as net income in FY2025 and turned 8 cents into free cash flow.

Operating income, FY2025

13% of revenue

▲ +1% vs FY2024 ($496.5M, 14%)

Net income, FY2025

10% of revenue

▲ +5% vs FY2024 ($374.5M, 10%)

Free cash flow, FY2025

8% of revenue

▼ −18% vs FY2024 ($366.9M, 10%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +6%; vs $966M in Q2 FY2025
Net income: ▼ −22%; vs $111.7M in Q2 FY2025

Pharma share of revenue vs 45.8% in Q2 FY2025

Sep 1, 2026 Gael Touya became CEO, succeeding Stephan Tanda Touya previously led Aptar Pharma and took the role after Tanda retired.

Growing. Revenue grew 17% in 4 years, from $3.2B in FY2021 to $3.8B in FY2025, about 4% a year.

Segment realignment The latest structure groups dispensing closures in a cross-market Closures segment serving food, beverage, personal care, home care and beauty, rather than the former Beauty + Home and Food + Beverage arrangement.

Revenue over time

Pharma Beauty Closures

$5B$2.5B$0

FY2023 FY2024 FY2025

Comments